U.S. Physical Therapy, Inc. (NYSE:USPH) Director Mark J. Brookner sold 2,500 shares of the business’s stock in a transaction that occurred on Friday, September 21st. The stock was sold at an average price of $116.00, for a total value of $290,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Mark J. Brookner also recently made the following trade(s):

  • On Friday, September 7th, Mark J. Brookner sold 625 shares of U.S. Physical Therapy stock. The stock was sold at an average price of $128.50, for a total value of $80,312.50.
  • On Thursday, August 23rd, Mark J. Brookner sold 4,375 shares of U.S. Physical Therapy stock. The stock was sold at an average price of $116.82, for a total value of $511,087.50.

Shares of U.S. Physical Therapy stock opened at $117.65 on Wednesday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.06 and a current ratio of 2.06. The company has a market capitalization of $1.48 billion, a price-to-earnings ratio of 56.56, a P/E/G ratio of 4.14 and a beta of 1.14. U.S. Physical Therapy, Inc. has a one year low of $59.05 and a one year high of $129.65.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Thursday, August 2nd. The company reported $0.73 EPS for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.05. The business had revenue of $115.10 million for the quarter, compared to analysts’ expectations of $111.77 million. U.S. Physical Therapy had a return on equity of 13.81% and a net margin of 5.03%. The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.59 EPS. equities analysts expect that U.S. Physical Therapy, Inc. will post 2.51 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, September 7th. Shareholders of record on Tuesday, August 14th were paid a $0.23 dividend. The ex-dividend date of this dividend was Monday, August 13th. This represents a $0.92 dividend on an annualized basis and a yield of 0.78%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 44.23%.

Institutional investors have recently made changes to their positions in the business. Northern Trust Corp increased its stake in shares of U.S. Physical Therapy by 10.3% during the second quarter. Northern Trust Corp now owns 217,737 shares of the company’s stock valued at $20,903,000 after buying an additional 20,295 shares during the period. Public Employees Retirement System of Ohio purchased a new position in shares of U.S. Physical Therapy during the second quarter valued at approximately $576,000. California Public Employees Retirement System increased its stake in shares of U.S. Physical Therapy by 3.9% during the second quarter. California Public Employees Retirement System now owns 42,767 shares of the company’s stock valued at $4,106,000 after buying an additional 1,602 shares during the period. Forsta AP Fonden purchased a new position in shares of U.S. Physical Therapy during the second quarter valued at approximately $672,000. Finally, grace capital increased its stake in shares of U.S. Physical Therapy by 515.9% during the second quarter. grace capital now owns 16,753 shares of the company’s stock valued at $1,608,000 after buying an additional 14,033 shares during the period. 98.17% of the stock is currently owned by institutional investors and hedge funds.

A number of equities analysts have commented on the company. Jefferies Financial Group reaffirmed a “hold” rating and issued a $105.00 price target on shares of U.S. Physical Therapy in a research note on Friday, August 3rd. Zacks Investment Research cut U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Saturday, July 7th. ValuEngine raised U.S. Physical Therapy from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, June 26th. Finally, Barrington Research reaffirmed a “hold” rating on shares of U.S. Physical Therapy in a research note on Friday, August 3rd. Five equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $108.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Further Reading: Technical Analysis

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.